Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Cash Flow-to-Debt Ratio
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Cash Flow-to-Debt Ratio of 0.20x as of September 2025, meaning its operating cash flow of CN¥400.70 Million could theoretically repay 0% of its total liabilities (CN¥2.05 Billion) in one year. See financial flexibility index of Shenzhen Salubris Pharmaceuticals Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see 002294 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year debt coverage analysis for Shenzhen Salubris Pharmaceuticals Co Ltd. Check 002294 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.69x | CN¥1.19 Billion | CN¥1.71 Billion | ▲ +6.8% |
| 2023 | 0.65x | CN¥869.79 Million | CN¥1.34 Billion | ▲ +18.8% |
| 2022 | 0.55x | CN¥970.80 Million | CN¥1.78 Billion | ▼ -44.8% |
| 2021 | 0.99x | CN¥1.18 Billion | CN¥1.20 Billion | ▼ -4.5% |
| 2020 | 1.04x | CN¥1.37 Billion | CN¥1.33 Billion | ▼ -26.7% |
| 2019 | 1.41x | CN¥1.51 Billion | CN¥1.07 Billion | ▲ +8.9% |
| 2018 | 1.30x | CN¥1.34 Billion | CN¥1.03 Billion | ▼ -37.2% |
| 2017 | 2.07x | CN¥1.46 Billion | CN¥705.86 Million | ▲ +54.6% |
| 2016 | 1.34x | CN¥1.43 Billion | CN¥1.07 Billion | ▼ -12.6% |
| 2015 | 1.53x | CN¥1.06 Billion | CN¥691.25 Million | ▲ +28.8% |
| 2014 | 1.19x | CN¥982.25 Million | CN¥827.95 Million | ▼ -9.8% |
| 2013 | 1.32x | CN¥668.52 Million | CN¥508.36 Million | ▼ -5.6% |
| 2012 | 1.39x | CN¥521.21 Million | CN¥374.02 Million | ▲ +58.9% |
| 2011 | 0.88x | CN¥272.32 Million | CN¥310.52 Million | ▲ +45.4% |
| 2010 | 0.60x | CN¥186.65 Million | CN¥309.50 Million | ▼ -33.3% |
| 2009 | 0.90x | CN¥134.28 Million | CN¥148.59 Million | ▲ +69.0% |
| 2008 | 0.53x | CN¥77.89 Million | CN¥145.70 Million | ▲ +11.5% |
| 2007 | 0.48x | CN¥52.75 Million | CN¥109.98 Million | ▲ +108.5% |
| 2006 | 0.23x | CN¥12.00 Million | CN¥52.19 Million | — |